Quanterix Releases Financial Results for the First Quarter of 2025

About this update from Quanterix Corporation

[{"type":"text","content":"BILLERICA, Mass., May 12, 2025--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the first quarter ended March 31, 2025.","length":248,"tagName":"p"},{"type":"text","content":""During a time when market resource constraints threaten to slow scientific progress, we remain committed to keeping the innovation engine moving forward," said Masoud Toloue, CEO of Quanterix. "Today, we are excited to announce a major advance: through a new early-access program, Simoa® ONE assay kits will become compatible with over 20,000 existing flow cytometers worldwide—significantly reducing the need for capital equipment purchases by current and future customers. This leap is enabled by a breakthrough in reagent design: Simoa’s digital, ultra-sensitive detection now operates with kinetic dye-encoded beads, dramatically expanding our reach to an installed base more than twenty times the size of our own. We are democratizing access to ultrasensitive biomarker detection by meeting researchers where they are—a major step forward in our mission to bring Simoa to all labs."","length":908,"tagName":"p"},{"type":"text","content":"Toloue continued, "Following a solid first quarter that exceeded our expectations, we are proactively positioning the company for long-term success. In light of ongoing market headwinds, we are taking a disciplined approach to guidance and implementing targeted cost reductions of approximately $30 million annually. These actions strengthen our path to generate positive cash flow by 2026, reinforce our commitment to sustainable innovation-driven growth, and help to streamline our coming integration with Akoya Biosciences."","length":537,"tagName":"p"},{"type":"text","content":"First Quarter Financial Highlights","length":34,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of $30.3 million, a decrease of 5% compared to $32.1 million in the prior year.","length":87,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":87,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"GAAP gross margin of 54.1%, as compared to 57.8% in the prior year. Adjusted gross margin (non-GAAP) of 49.7% as compared to 51.2% in t...

More updates from Quanterix Corporation